Exploring the role of flavonoids in caries-affected dentin adhesion: A comprehensive scoping review.

OBJECTIVES: The aim of this scoping review was to evaluate the available scientific evidence regarding the use of flavonoids in the treatment of caries-affected dentin focusing on bonding to dentin. METHODS: A comprehensive literature search was performed in five databases from March 2022 and updated in April 2023: PubMed, EMBASE, Scopus, Web of Science, and Scielo. Additionally, the references of included studies were manually searched. Gray literature was excluded from the review. STUDY SELECTION: Inclusion criteria included in vitro, in situ, and in vivo studies (animal or human) published in English. Abstracts, reviews, case reports, book chapters, doctoral dissertations, guidelines, and studies using pure plant extracts were excluded. Data collected from the selected studies were summarized and subjected to narrative and descriptive analysis. Out of the 91 studies identified, only 16 studies met the inclusion criteria. RESULTS: The review analyzed eight different flavonoids (hesperidin, galardin, proanthocyanidin, genipin, quercetin, naringin, epigallocatechin-3-gallate, and other catechins subtypes) used as pretreatment or loaded into adhesive systems, primers, and phosphoric acid. The use of flavonoids improved the mechanical properties of the materials and modified the biological properties of the dentin, reducing collagen loss by the inhibition of proteolytic activity of matrix metalloproteinases (MMPs). CONCLUSIONS: Based on the findings of this scoping review, it can be concluded that the use of flavonoids as pretreatment or incorporation into dental materials preserves collagen in the hybrid layer, inhibiting the MMPs activities, modifying the collagen fibrils of the dentin matrix and improving the mechanical properties of the dental adhesive systems. Therefore, it represents a promising approach for promoting dentin biomodification. This can result in more stable bonding of adhesive restorations to caries-affected dentin.

Use of electronic cigarettes and hookah in Brazil: a new and emerging landscape. The Covitel study, 2022.

OBJECTIVE: To estimate the prevalence of current commercial cigarette smoking, as well as those of e-cigarette and hookah experimentation and current use among adults (≥ 18 years of age) in Brazil. METHODS: This study was based on a countrywide cross-sectional telephone-based survey conducted in 2022. The sample was designed to be representative of the five macroregions in Brazil and included 1,800 individuals from each of the regions. Telephone numbers, using a random digit dialing procedure, were proportionally selected for each direct distance dialing code in each region and then electronically validated (i.e., 900 cell and 900 landline phone numbers per region). Information on current commercial cigarette smoking (regardless of frequency/amount), as well as lifetime history of or current e-cigarette and hookah use (regardless of amount), were collected. RESULTS: The prevalence of lifetime history of e-cigarette and hookah use was identical (7.3%; 95% CI: 6.0-8.9), whereas the prevalence of current commercial cigarette smoking was 12.2% (95% CI: 10.4-14.1). Young adults (18-24 years) had the highest prevalence of e-cigarette experimentation (19.7%; 95% CI: 15.1-17.0) and hookah experimentation (17%; 95% CI: 12.2-23.2). E-cigarette and hookah use was more common in the Central-West region and among those with a high level of education, whereas current commercial cigarette smoking was more common among those with a lower level of education. Individuals who used the three forms of nicotine delivery corresponded to 1.5% of the sample (nearly 2 million individuals based on the estimated size of the Brazilian adult population). CONCLUSIONS: Surveillance is essential for the monitoring and prevention of these new forms of nicotine consumption.

Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial.

INTRODUCTION: Fibromyalgia is a complex, generalized, and diffuse chronic musculoskeletal pain. Pharmacological approaches are widely used to relieve pain and increase quality of life. Low-Dose Naltrexone (LDN) was shown to increase the nociceptive threshold in patients with fibromyalgia. Transcranial Direct Current Stimulation (tDCS) is effective for pain management. OBJECTIVE: The purpose of this study was to evaluate the analgesic and neuromodulatory effects of a combination of LDN and tDCS in patients with fibromyalgia. METHODS: This was a randomized, double-blinded, parallel, placebo/sham-controlled trial (NCT04502251; RBR-7HK8N) in which 86 women with fibromyalgia were included, and written informed consent was obtained from them. The patients were allocated into four groups: LDN + tDCS (n = 21), LDN + tDCS Sham (n = 22), placebo + tDCS (n = 22), and placebo+tDCS Sham (n = 21). The LDN or placebo (p.o.) intervention lasted 26 days; in the last five sessions, tDCS was applied (sham or active, 20 min, 2 mA). The following categories were assessed: sociodemographic, Visual Analog Pain Scale (VAS), Pain Catastrophizing Scale (PCS), State-Trait Anxiety Inventory (STAI), Fibromyalgia Impact Questionnaire (FIQ), Beck Depression Inventory (BDI-II), Profile of Chronic Pain Scale (PCP:S), Pain Pressure Threshold (PPT), and Conditioned Pain Modulation (CPM). Blood samples were collected to analyze BDNF serum levels. RESULTS: At baseline, no significant difference was found regarding all measurements. VAS pain was significantly reduced in the LDN + tDCS (p = 0.010), LDN + tDCS Sham (p = 0.001), and placebo+tDCS Sham (p = 0.009) groups. In the PCP:S, the LDN+tDCS group showed reduced pain frequency and intensity (p = 0.001), effect of pain on activities (p = 0.014) and emotions (p = 0.008). Depressive symptoms reduced after all active interventions (p > 0.001). CONCLUSION: Combined LDN+tDCS has possible benefits in reducing pain frequency and intensity; however, a placebo effect was observed in pain using VAS, and further studies should be performed to analyze the possible association.

Use of electronic cigarettes and hookah in Brazil: a new and emerging landscape. The Covitel study, 2022 / Uso de cigarro eletrônico e narguilé no Brasil: um cenário novo e emergente. O estudo Covitel, 2022

ABSTRACT Objective: To estimate the prevalence of current commercial cigarette smoking, as well as those of e-cigarette and hookah experimentation and current use among adults (≥ 18 years of age) in Brazil. Methods: This study was based on a countrywide cross-sectional telephone-based survey conducted in 2022. The sample was designed to be representative of the five macroregions in Brazil and included 1,800 individuals from each of the regions. Telephone numbers, using a random digit dialing procedure, were proportionally selected for each direct distance dialing code in each region and then electronically validated (i.e., 900 cell and 900 landline phone numbers per region). Information on current commercial cigarette smoking (regardless of frequency/amount), as well as lifetime history of or current e-cigarette and hookah use (regardless of amount), were collected. Results: The prevalence of lifetime history of e-cigarette and hookah use was identical (7.3%; 95% CI: 6.0-8.9), whereas the prevalence of current commercial cigarette smoking was 12.2% (95% CI: 10.4-14.1). Young adults (18-24 years) had the highest prevalence of e-cigarette experimentation (19.7%; 95% CI: 15.1-17.0) and hookah experimentation (17%; 95% CI: 12.2-23.2). E-cigarette and hookah use was more common in the Central-West region and among those with a high level of education, whereas current commercial cigarette smoking was more common among those with a lower level of education. Individuals who used the three forms of nicotine delivery corresponded to 1.5% of the sample (nearly 2 million individuals based on the estimated size of the Brazilian adult population). Conclusions: Surveillance is essential for the monitoring and prevention of these new forms of nicotine consumption.

RESUMO Objetivo: Estimar a prevalência do consumo atual de cigarros industrializados, bem como da experimentação e uso atual de cigarro eletrônico e narguilé entre adultos (≥ 18 anos) no Brasil. Métodos: Este estudo baseou-se em uma inquérito telefônico nacional realizada em 2022. A amostra foi projetada para ser representativa das cinco macrorregiões do Brasil e foi composta por 1.800 indivíduos de cada uma das regiões. Por meio de um procedimento de discagem aleatória, os números de telefone foram selecionados proporcionalmente para cada código de discagem direta à distância em cada região e, em seguida, validados eletronicamente (isto é, 900 telefones celulares e 900 telefones fixos por região). Foram coletadas informações sobre o consumo atual de cigarros industrializados (independentemente da frequência/quantidade), bem como sobre a história de uso ou uso atual de cigarro eletrônico e narguilé (independentemente da quantidade). Resultados: As prevalências de história de uso de cigarro eletrônico e narguilé foram idênticas (7,3%; IC95%: 6,0-8,9), ao passo que a prevalência de consumo atual de cigarros industrializados foi de 12,2% (IC95%: 10,4-14,1). Adultos jovens (18-24 anos) apresentaram as maiores prevalências de experimentação de cigarro eletrônico (19,7%; IC95%: 15,1-17,0) e de narguilé (17%; IC95%: 12,2-23,2). O uso de cigarro eletrônico e narguilé foi mais comum na região Centro-Oeste e entre aqueles com maior grau de escolaridade, ao passo que o consumo atual de cigarros industrializados foi mais comum entre aqueles com menor grau de escolaridade. Os indivíduos que usavam as três formas de liberação de nicotina corresponderam a 1,5% da amostra (quase 2 milhões de indivíduos com base na estimativa do tamanho da população adulta brasileira). Conclusões: A vigilância é essencial para o monitoramento e prevenção dessas novas formas de consumo de nicotina.

Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial

Abstract Introduction Fibromyalgia is a complex, generalized, and diffuse chronic musculoskeletal pain. Pharmacological approaches are widely used to relieve pain and increase quality of life. Low-Dose Naltrexone (LDN) was shown to increase the nociceptive threshold in patients with fibromyalgia. Transcranial Direct Current Stimulation (tDCS) is effective for pain management. Objective The purpose of this study was to evaluate the analgesic and neuromodulatory effects of a combination of LDN and tDCS in patients with fibromyalgia. Methods This was a randomized, double-blinded, parallel, placebo/sham-controlled trial (NCT04502251; RBR-7HK8N) in which 86 women with fibromyalgia were included, and written informed consent was obtained from them. The patients were allocated into four groups: LDN + tDCS (n = 21), LDN + tDCS Sham (n = 22), placebo + tDCS (n = 22), and placebo+tDCS Sham (n = 21). The LDN or placebo (p.o.) intervention lasted 26 days; in the last five sessions, tDCS was applied (sham or active, 20 min, 2 mA). The following categories were assessed: sociodemographic, Visual Analog Pain Scale (VAS), Pain Catastrophizing Scale (PCS), State-Trait Anxiety Inventory (STAI), Fibromyalgia Impact Questionnaire (FIQ), Beck Depression Inventory (BDI-II), Profile of Chronic Pain Scale (PCP:S), Pain Pressure Threshold (PPT), and Conditioned Pain Modulation (CPM). Blood samples were collected to analyze BDNF serum levels. Results At baseline, no significant difference was found regarding all measurements. VAS pain was significantly reduced in the LDN + tDCS (p = 0.010), LDN + tDCS Sham (p= 0.001), and placebo+tDCS Sham (p= 0.009) groups. In the PCP:S, the LDN+tDCS group showed reduced pain frequency and intensity (p= 0.001), effect of pain on activities (p= 0.014) and emotions (p= 0.008). Depressive symptoms reduced after all active interventions (p > 0.001). Conclusion Combined LDN+tDCS has possible benefits in reducing pain frequency and intensity; however, a placebo effect was observed in pain using VAS, and further studies should be performed to analyze the possible association.

eHealthResp, a Digital Intervention to Improve Antibiotic Prescribing in Respiratory Infections: A Pilot Study.

The emergence of antibiotic resistance (ABR) is one of the most serious public health threats worldwide. The inappropriate use of antibiotics is considered the main determinant for the increase and development of ABR, contributing to a greater risk of therapeutic ineffectiveness, particularly within primary care context. Therefore, this pilot study aims to raise awareness and promote an adequate antibiotic use among physicians, through the evaluation of the eHealthResp platform, a digital intervention composed by an online course and a mobile application, to aid in the management of respiratory tract infections. The global validation of the eHealthResp platform was carried out by 12 physicians who explored and performed a quantitative and qualitative evaluation of the contents of the online course and mobile app. The global evaluation of the analyzed parameters was very positive, with the highest median scores being attributed to adequacy, correction, format, and trust of the eHealthResp platform. The qualitative feedback enhanced the contents' relevance, clarity, and consolidation, as well as the effectiveness of the educational intervention against ABR. Overall, this study revealed that the eHealthResp may be regarded as an important e-health tool for the management of respiratory tract infections and improvement of antibiotic prescription practices among physicians.

Improving Pharmacists' Awareness of Inadequate Antibiotic Use for URTIs through an Educational Intervention: A Pilot Study.

The inadequate use of antibiotics led to the development of multi-resistant bacteria that are now causing millions of deaths worldwide. Since most antibiotics are prescribed/dispensed to treat respiratory tract infections, it is important to raise awareness among health professionals to optimize antibiotic use, especially within the primary care context. Thus, this pilot study aimed to evaluate pharmacists' feedback about the eHealthResp platform, composed by an online course and a mobile application (app) to help in the management of upper respiratory tract infections (URTIs). Ten community pharmacists were invited to participate in this study, exploring the contents of the eHealthResp platforms and answering a content validation questionnaire composed by eight qualitative and thirty-five quantitative questions about the online course and mobile app. The eHealthResp platform is a comprehensive, consistent, and high-quality e-learning tool. Median scores of 5.00 were attributed to the course contents' and clinical cases' adequacy and correction. Most qualitative feedback was about completeness and objectivity of the course, and its usefulness for clinical practice. This study showed that eHealthResp has great potential as an e-health tool for the management of URTIs' symptoms, which may ultimately aid in reducing inappropriate antibiotic use.

Narrativas antivacinas e a crise de confiança em algumas instituições / Anti-vaccine narratives and the crisis of trust in some institutions / Narrativas antivacunas y crisis de confianza en algunas instituciones

As narrativas antivacinas vêm ganhando força ao redor do mundo e têm sido foco de preocupação de autoridades de saúde nacionais e internacionais. Este artigo tem como objetivo principal analisar as narrativas postadas em dois grupos antivacinas no Facebook publicadas em 2020, quando o mundo iniciava o enfrentamento da pandemia de covid-19. A estratégia metodológica utilizada para alcançar o objetivo e ancorar as análises é o Mapa das Mediações, de Martín-Barbero. Os resultados revelam, entre outros pontos, que as narrativas antivacinas estão, em grande parte, relacionadas com uma desconfiança em duas instituições: a ciência e o Estado. Isso permite o desdobramento de novos estudos focados no desenvolvimento de políticas públicas para o combate à desinformação sobre a saúde nos meios de comunicação.

Anti-vaccine narratives have been gaining strength around the world and have been a focus of concern of national and international health authorities. This article has as main objective to analyze the narratives posted in two anti-vaccine groups on Facebook, published in 2020, when the world was starting the fighting against the covid-19 pandemic. The methodological strategy to achieve the objective and anchor the analyzes is the Map of Mediations, produced by Martín-Barbero. The results reveal, among other points, that the antivaccine narratives are connected with a distrust in two institutions: the science and the State, allowing the development of new studies focused on public policies to combat misinformation about health in the media.

Las narrativas contra las vacunas están ganando fuerza en todo el mundo y están siendo un foco de preocupación para las autoridades sanitarias nacionales e internacionales. Este artículo tiene como objetivo principal analizar las narrativas publicadas en dos grupos antivacunas en Facebook, en 2020, cuando el mundo empezó a luchar contra la pandemia de covid-19. La estrategia metodológica utilizada para lograr el objetivo y realizar los análisis es el Mapa de las mediaciones, evidenciado por Martín-Barbero. Los resultados revelan, entre otros puntos, que las narrativas antivacuna están conectadas con la desconfianza en dos instituciones: la ciencia y el Estado, lo que permite el desarrollo de nuevos estudios enfocados en políticas públicas para combatir la desinformación sobre salud en los medios de comunicación.

A influência da estrutura social na disseminação de comportamentos e de informações falsas em saúde / The influence of social structure on the dissemination of behaviors and false health information

Informações são disseminadas de forma simples e comportamentos se espalham de forma complexa. Nesse sentido, uma melhor compreensão de como tomamos decisões pode colaborar para a criação de estratégias que estimulam mudanças comportamentais, auxiliando medidas de prevenção na saúde e inibindo a proliferação de notícias falsas. Por isso, este ensaio tem como objetivo levantar uma discussão sobre como aestrutura social pode influenciar a adesão de novos hábitos e a disseminação de informações falsas. Mudanças comportamentais exigem mecanismos sociais como legitimidade, credibilidade, complementaridade e conexão emocional para possibilitar sua disseminação. Compreender os mecanismos sociais de comportamento é fundamental para elaborar estratégias eficazes em intervenções na saúde pública.

Sifilis adquirida

O vídeo apresenta os tipos de sífilis adquirida, as formas de transmissão, os tipos de exames necessários para detectar e tratar a doença, a terapêutica e as reações que ocorrem devido a terapêutica utilizada.